What is Bio-Rad Laboratories, Inc. Class B's Market Cap?

Bio-Rad Laboratories, Inc. Class B's Market Cap is $10.8B, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc. Class B's Enterprise Value?

Bio-Rad Laboratories, Inc. Class B's Enterprise Value is $10.0B, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc. Class B's Trailing P/E?

Bio-Rad Laboratories, Inc. Class B's Trailing P/E is 48.6×, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc. Class B's Price / Sales?

Bio-Rad Laboratories, Inc. Class B's Price / Sales is 4.2×, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc. Class B's EV / Revenue?

Bio-Rad Laboratories, Inc. Class B's EV / Revenue is 3.9×, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc. Class B's EV / EBITDA?

Bio-Rad Laboratories, Inc. Class B's EV / EBITDA is 43.2×, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc. Class B's Revenue (TTM)?

Bio-Rad Laboratories, Inc. Class B's Revenue (TTM) is $2.6B, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc. Class B's Net Income (TTM)?

Bio-Rad Laboratories, Inc. Class B's Net Income (TTM) is $222.4M, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc. Class B's EBITDA?

Bio-Rad Laboratories, Inc. Class B's EBITDA is $218.5M, based on as-reported figures from SEC (XBRL) filings.

What is Bio-Rad Laboratories, Inc. Class B's Diluted EPS (TTM)?

Bio-Rad Laboratories, Inc. Class B's Diluted EPS (TTM) is 8.32, based on as-reported figures from SEC (XBRL) filings.

Bio-Rad Laboratories, Inc. Class B (BIO.B) Financial Statements

Bio-Rad Laboratories, Inc. Class B

SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS

FIGI BBG001S5P622

XNYS · usd

404.26▲ 39.18 (10.73%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close365.08

Day's Range365.08 – 365.08

52-Week Range244.54 – 365.08

Volume102

Avg Volume243

Share Statistics

Shares Outstanding

Employees7,450

ExchangeXNYS

Listed1899-12-30

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Bio-Rad Laboratories, Inc. Class B (BIO.B)

What is Bio-Rad Laboratories, Inc. Class B's Market Cap?: Bio-Rad Laboratories, Inc. Class B's Market Cap is $10.8B, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc. Class B's Enterprise Value?: Bio-Rad Laboratories, Inc. Class B's Enterprise Value is $10.0B, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc. Class B's Trailing P/E?: Bio-Rad Laboratories, Inc. Class B's Trailing P/E is 48.6×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc. Class B's Price / Sales?: Bio-Rad Laboratories, Inc. Class B's Price / Sales is 4.2×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc. Class B's EV / Revenue?: Bio-Rad Laboratories, Inc. Class B's EV / Revenue is 3.9×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc. Class B's EV / EBITDA?: Bio-Rad Laboratories, Inc. Class B's EV / EBITDA is 43.2×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc. Class B's Revenue (TTM)?: Bio-Rad Laboratories, Inc. Class B's Revenue (TTM) is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc. Class B's Net Income (TTM)?: Bio-Rad Laboratories, Inc. Class B's Net Income (TTM) is $222.4M, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc. Class B's EBITDA?: Bio-Rad Laboratories, Inc. Class B's EBITDA is $218.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc. Class B's Diluted EPS (TTM)?: Bio-Rad Laboratories, Inc. Class B's Diluted EPS (TTM) is 8.32, based on as-reported figures from SEC (XBRL) filings.